New way to study molecular drivers of cancer
Clearer understanding about the markers and drivers of cancer cell proliferation has emerged from research that identifies new opportunities to overcome convergence with complex enzymes, known […]
Critical oncology trial data remains hidden
Despite a commitment from the pharmaceutical industry in 2014 to improve data transparency, more than half of the clinical trials that led to the United States […]
Contrasting rates of survival for GI cancers in NT
Survival rates for gastrointestinal (GI) cancer among Northern Territorians have improved in the past 30 years but Aboriginal and Torres Strait Islander peoples living in the […]
Gut medication hindering lung cancer treatment
A common medication used to treat reflux, heart burn and ulcers could lessen the effectiveness of lung cancer immunotherapy drugs, according to new Flinders University research. […]
Improving survival of rare cancer for Indigenous Australians
Improving survival rates for cancers of unknown primary (CUP) and reducing the proportion of Indigenous Australians diagnosed with CUP will be the focus of a new […]
Blood test for personalised cancer treatment
A blood test to help guide the treatment of oesophageal, stomach and bowel cancers will be evaluated in a new Flinders University trial set to get […]
Slowly, steadily finding clues to ageing and cancer cure
New research into the genome of the world famous giant tortoise, Lonesome George, provides extraordinary insights into the species’ large size, ability to live up to […]
Money stress for 1 in 5 with cancer
On top of worrying about treatments and side effects, many people with cancer also worry about the cost of their care. In a new study, Australian […]
How to spark a chemical chain reaction
Tailor-made protein drugs in the fight against cancer and other diseases are a step closer, with the Centre for NanoScale Science and Technology at Flinders playing […]